Evaluating outcomes of veno arterial ECMO therapy
Official title: In-hospital Mortality of Patients With Veno Arterial ECMO: a Prospective Observational Study
Run by Centre Hospitalier Universitaire, Amiens · NCT05155904 · Data updated 2026-11-12
This study looks at patients using a special heart-lung machine called VA ECMO to see how it affects their chances of surviving serious heart problems.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Locations | 1 site (Amiens) |
| Status | Recruiting |
| Started | November 16, 2021 |
| Main results expected | November 2026 |
| Study ends | November 2026 |
| Registry record updated | February 8, 2023 |
| Trial ID | NCT05155904 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who are undergoing veno arterial ECMO treatment.
✕Probably not a fit
Patients under the age of 18 will not benefit from this study as they are excluded from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on patients who are receiving veno arterial (VA) extracorporeal membrane oxygenation (ECMO) as a rescue therapy for severe cardiac conditions such as refractory cardiac arrest and cardiogenic shock. Conducted at the Amiens hospital university, the study aims to assess the mortality rates associated with VA ECMO, which currently has a low survival rate at hospital discharge. By analyzing patient outcomes, the study seeks to identify factors influencing survival and improve treatment protocols for this high-risk population.
Why it matters
Potential benefit: If successful, this study could lead to improved survival rates and better management strategies for patients requiring VA ECMO.
How similar studies have gone: While there have been studies on ECMO outcomes, this specific observational approach focusing on VA ECMO mortality is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age : ≥ 18 * Patient with a VA ECMO Exclusion Criteria: * age\<18
Where it's running
-
CHU Amiens Picardie
Amiens, France Recruiting
Study contacts
- Study coordinator: Osama Abou Arab, MD
- Email: abouarab.osama@chu-amiens.fr
- Phone: 03 22 08 78 36
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Modeling blood flow in children's brains after ECMO treatment
This study looks at how two different methods for removing ECMO affect blood flow in the brains of young children who weigh less than 20 kg.
-
Optimized Flow for Obese Patients Undergoing Heart Surgery
In this study, researchers will test whether using ideal body weight to set cardiopulmonary bypass flow during heart surgery helps obese adults see fewer transfusions and related complications.
-
See if small fiber neuropathy is common in people with primary Sjögren’s syndrome
This study tests whether small fiber neuropathy is common in adults with primary Sjögren’s syndrome using a quick, non-invasive Sudoscan test.
-
Tramadol vs Morphine for Postoperative Pain After Laparoscopic Abdominal Surgery
This study tests whether tramadol can provide comparable pain relief to morphine after laparoscopic abdominal surgery when used as part of multimodal pain management.
-
Using infrared cameras to help detect juvenile arthritis in kids
This study tests whether infrared thermography can help identify joint inflammation in children with juvenile idiopathic arthritis compared with standard tests.
-
Hypothalamus structure and heart autonomic changes in drug-resistant epilepsy
This study tests whether structural changes in the hypothalamus relate to cardiac autonomic dysfunction in adults with drug-resistant epilepsy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.